BIOPOR.CO Stock Chart

BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients. The Company offers the neutrophil gelatinase-associated lipocalin (NGAL) test, a particle-enhanced turbidimetric immunoassay for measuring NGAL in urine and plasma on automated clinical chemistry analyzers; NGAL enzyme-linked immunosorbent assay (ELISA) kits for various animal models used in research, as well as for human use; and mannose-binding lectin (MBL) ELISA kit, which is based on MBL antibodies.